Salam Kabbani

ASP Pharmacist 💊PASC🦠 She/Her/Hers 🚫Medical Advice *Opinions are my own*

[Salam Kabbani @LHchronicles]

No content I share is a substitute for medical advice!

[Contagion @Contagion_Live]

The @WHO has declared the #Ebola outbreak caused by Bundibugyo virus in countries in a Public Health Emergency of International Concern, citing cross-border spread, rising suspected cases, and the absence of approved vaccines or treatments. #IDtwitter
https://t.co/IJT4GCx6FF

[Lindsay McAlpine MD @McAlpineLabYale]

Pleased to share our latest COVID Mind Study @ Yale publication: "Vascular inflammation in neuropsychiatric long COVID" Elevated markers of endothelial adhesion in LC correlates with lower verbal fluency and learning.
https://t.co/KeXUAnIhpD

[Deeksha J. Ladani, MD @transplantID]

https://t.co/yDE9oktXfN

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕⚡🔴American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2025 Guidelines for the Management of Infectious and Inflammatory Lesions of the Breast #IDXposts
https://t.co/rAFfGVYAPR

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕⚡🟢The REVIVE Trial
The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID
Participants were randomly assigned to fluvoxamine (100 mg twice daily), metformin (750 mg twice daily), or matching placebo for 60 days
Fluvoxamine showed a significant reduction in fatigue compared with placebo at day 60 (mean difference, −0.43 [95% credible interval {CrI}, −0.80 to −0.07]), with a sustained effect at day 90 (mean difference, −0.58 [CrI, −0.98 to −0.16]). Fluvoxamine also improved quality-of-life scores with high posterior probability. Metformin showed no significant benefit. Adverse events were less frequent with fluvoxamine (20.0%) than with metformin (28.8%) or placebo (29.7%). Grade 3 and higher adverse events were rare across all groups #IDXposts
https://t.co/DyyYDbsh8w

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Statement that is unfortunately consistent With 2021 Surviving Sepsis Campaign Guidelines
10. For adults with sepsis-induced hypoperfusion or septic shock, we “suggest” administering at least 30 mL/kg of IV crystalloid in the first 3 hr(conditional recommendation, low certainty evidence)
Although evidence in support of 30 mL/kg stems from observational studies and includes studies evaluating 30 mL/kg as part of a bundle of care practices, there are no new data suggesting a change is needed from prior SSC guidelines. Fluid overload generally occurs with volumes far exceeding 30 mL/kg.
However, in patients at higher risk of harms from volume overload, dynamic assessment to guide fluid resuscitation can commence prior to 30 mL/kg.

[Salam Kabbani @LHchronicles]

@ABsteward Eid Mubarak! Thanks for keeping us up to date on everything ID! :)

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Happy Eid on @ABsteward style
🆕⚡🔥Mini Review by 🌟 Dr.Patricia Simner
The shift from “MIC-Only” back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance
This minireview summarizes the evolution of CLSI guidance from early breakpoint establishment through the “MIC-only” era to the current antimicrobial resistance mechanism-driven framework. #IDXposts https://t.co/I2ocVOf4iU

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Ramadan Mubarak on @ABsteward style! ! 🌙✨

[ACCP INFD PRN @accpinfdprn]

Hot off the Press! ♨️📜

State-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis 🦠💊🏥

Open access at 🔗: https://t.co/F1aC4gZdx6

[ACCP INFD PRN @accpinfdprn]

New in ID: Early November papers you shouldn’t miss.✨ #IDXposts

[Clinical Infectious Diseases @CIDJournal]

Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods

✅ Just Accepted
🔗 https://t.co/PCoNV5njwK

[Salam Kabbani @LHchronicles]

I believe that medical care no matter the politics means that every human deserves access to food and medicine. I implore healthcare workers to take 5 min and call to stop the famine.

[TUKHS Olathe Pharmacy Residency @OlatheRxRes]

Happy Juneteenth! May we all take today to celebrate the freedom of those who were enslaved, and to continue listening to each other and growing for a brighter future for all!

#tukhsolathepgy1 #pharmacyresidency #juneteenth

[TUKHS Olathe Pharmacy Residency @OlatheRxRes]

Today our ASP/ID pharmacist, Salam Kabbani, and our PGY1 resident Wendy Chen, presented a clinical controversy on linezolid dosing in obese patients.
.
.
#tukhspgy1 #pharmacyresidency #TwitteRx

[Dr. Alice 💕 @calirunnerdoc]

We’ve known for years that reinfection commonly derails clinical improvement in #LongCovid.

Yet, apart from NPIs, @NIH & @CDCgov & @US_FDA have NO APPROVED, ACCESSIBLE, & SAFE OPTIONS for reinfection prevention in LC.

Many w/ LC can’t even get safe healthcare.

Unacceptable.

[TUKHS Olathe Pharmacy Residency @OlatheRxRes]

Applications are due today!
.
.
#tukhsolathepgy2 #pharmacyresidency #phase2match #phorcas #TwitteRx

[Salam Kabbani @LHchronicles]

Feel free to reach out! We have an amazing program!

#TwitteRx

[TUKHS Olathe Pharmacy Residency @OlatheRxRes]

We are recruiting 2 PGY1 residents for phase 2 of the match. Learn more about our program here: https://t.co/Tsgq8OSElZ

#TwitteRx

[Salam Kabbani @LHchronicles]

Congratulations to all who matched! If you are participating in phase 2 for PGY1 we have 2 open positions at The University of Kansas Health System-Olathe Hospital!

Our program NMS code is 218013.
#phase2 #pharmacyresidency #match #phase2match #TwitterRx #TwitteRx #RxTwitter

[Salam Kabbani @LHchronicles]

I am flabbergasted that the STI and vaccination guidelines are no longer accessible on the CDC website.

I don’t post political views on here but when politics are now endangering the lives of our patients, I can’t stay silent.